Form 4: HealthStream Inc. Executive Awarded Restricted Share Units
SEC Form 4 Filing
Kevin P. O'Hara, Senior Vice President at HealthStream Inc., received 2,240 restricted share units (RSUs) on March 20, 2024, according to a Form 4 filing.
Summary
- A Form 4 filing reveals that Kevin P. O'Hara, a Senior Vice President at HealthStream Inc., was granted 2,240 restricted share units (RSUs) on March 20, 2024.
- These RSUs represent the contingent right to receive one share of common stock upon vesting.
- The RSUs are subject to a four-year vesting schedule, contingent upon continued service.
- The vesting schedule is as follows: 15% on March 20, 2025, 20% on March 20, 2026, 30% on March 20, 2027, and the remaining 35% on March 20, 2028.
- Following the transaction, O'Hara directly holds 2,240 derivative securities and 8,478 common stock holdings.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of executive compensation. It's neutral to slightly positive as it indicates the company is investing in its leadership.
Positives
- The granting of RSUs to a senior executive suggests the company is incentivizing long-term performance and retention.
Risks
- The value of the RSUs is tied to the performance of HealthStream's common stock, which can be subject to market fluctuations.
Future Outlook
The executive's compensation is tied to the company's stock performance over the next four years, aligning their interests with those of shareholders.
Industry Context
Granting stock-based compensation is a common practice in the healthcare technology industry to attract and retain top talent.
Comparison to Industry Standards
- Stock-based compensation is a standard practice among publicly traded companies, particularly in the technology and healthcare sectors.
- Companies like Cerner (now Oracle Health) and Allscripts also utilize RSUs and stock options as part of their executive compensation packages.
- The vesting schedule of four years is fairly typical, aligning with industry norms for long-term incentive plans.
Stakeholder Impact
- Shareholders may view the RSU grant positively as it aligns executive interests with long-term company performance.
- Employees may see this as a positive sign of investment in leadership.
Key Dates
| Date | Description |
|---|---|
| 03/20/2024 | Date of transaction: Grant of 2,240 restricted share units. |
| 03/20/2025 | 15% of RSUs vest. |
| 03/20/2026 | 20% of RSUs vest. |
| 03/20/2027 | 30% of RSUs vest. |
| 03/20/2028 | 35% of RSUs vest. |
| 03/21/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.